(Q44552407)

English

In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

phosphorylation

0 references

1 reference

based on heuristic

inferred from title

author name string

M Tanaka

1

1 reference

Europe PubMed Central

4 December 2017

H B Grossman

2

1 reference

Europe PubMed Central

4 December 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

10

1 reference

Europe PubMed Central

4 December 2017

19

1 reference

Europe PubMed Central

4 December 2017

1636-1642

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302056

0 references

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

The treated natural history of high risk superficial bladder cancer: 15-year outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

The implications of angiogenesis for the biology and therapy of cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

PTEN controls tumor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Interaction of cisplatin, paclitaxel and adriamycin with the tumor suppressor PTEN.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Somatic mutation of PTEN in bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Improved growth of human urothelial carcinoma cell cultures.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

The monoclonal antibody BQ16 identifies the alpha 6 beta 4 integrin on bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Methods for construction of adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with Cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Expression of MDR-1 Gene in Transitional Cell Carcinoma and its Correlation with Chemotherapy Response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

21 January 2018

Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of multiple drug resistance in human bladder cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302056

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302056

1 reference

Europe PubMed Central

4 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44552407&oldid=2027702080"